Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.61
+0.02 (0.05%)
At close: Apr 15, 2026, 4:00 PM EDT
39.05
-0.56 (-1.41%)
After-hours: Apr 15, 2026, 4:40 PM EDT

Centessa Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '20
Net Income
-197.53-235.76-151.09-216.21-10.66
Depreciation & Amortization
0.920.940.810.13-
Stock-Based Compensation
30.9633.5529.3924.970.34
Other Adjustments
1.8637.05-20.63-6.780.24
Changes in Accounts Payable
0.05-4.59-2.726.35-0.05
Changes in Accrued Expenses
-15.2222.77-0.86.260.65
Changes in Other Operating Activities
-14.863.98-15.31-15.27-1.15
Operating Cash Flow
-193.82-142.06-160.34-200.55-10.63
Capital Expenditures
-0.37-0.03-0.17-1.14-
Purchases of Investments
-739.76-140.53-264.91--
Proceeds from Sale of Investments
321.6171.83138.08--
Other Investing Activities
---0.21-
Investing Cash Flow
-418.5331.27-127-0.93-
Long-Term Debt Issued
-109.34--1.36
Long-Term Debt Repaid
--110.1---
Net Long-Term Debt Issued (Repaid)
--0.76--1.36
Issuance of Common Stock
296.72370.8321.120.720
Repurchase of Common Stock
-4.79-5.32---
Net Common Stock Issued (Repurchased)
291.93365.5121.120.720
Other Financing Activities
-0.4---0.26-
Financing Cash Flow
291.53364.7521.120.461.36
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.451.230.62-0.42-0.08
Net Cash Flow
-321.27255.19-265.61-201.44-9.34
Free Cash Flow
-194.19-142.09-160.51-201.68-10.63
FCF Margin
-1294.59%--2342.20%--
Free Cash Flow Per Share
-1.43-1.24-1.67-2.16-2.71
Levered Free Cash Flow
-227.01-213.45-169.27-219.87-9.85
Unlevered Free Cash Flow
-239.1-180.44-165.11-215.2-10.99
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q